Condition
Mesothelioma
Estimated Enrollment: 15
Age Group: 18 Years and older (Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: Open Label|Primary Purpose: Treatment
Study ID Numbers: 14-008715
Study First Received: May 14, 2015
Last Updated: December 20, 2016
Estimated Primary Completion Date: June 2017
Primary Outcome Measures:
Number of Participants with Adverse Events|Mean Number of Tumor Infiltrating Immune Cells as Measured by Immunohistochemistry on Participant Tissue Samples
Sponsors and Collaborators:
Mayo Clinic|CSA Medical, Inc.
Website Link: https://ClinicalTrials.gov/show/NCT02464904
